Vasgen

London, United Kingdom Founded: 2011 • Age: 15 yrs
Biotech company focused on developing therapeutics for ocular and cancer treatments.

About Vasgen

Vasgen is a company based in London (United Kingdom) founded in 2011 by Salman Rahman and Yatin Patel. It operates as a B2B. The company has 2 employees as of July 31, 2021. Vasgen offers products and services including AbIMP® Technology, ADAMs Family, and ADAM15. Vasgen operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.

  • Headquarter London, United Kingdom
  • Employees 2 as on 31 Jul, 2021
  • Founders Salman Rahman, Yatin Patel
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Vasgen Limited
  • Date of Incorporation 08 Jul, 2011
  • Jurisdiction LONDON
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    2

    as on Jul 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Vasgen

Vasgen offers a comprehensive portfolio of products and services, including AbIMP® Technology, ADAMs Family, and ADAM15. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Platform using monoclonal antibodies to inhibit metzincin proteases.

Focuses on cellular sheddases as emerging biomarkers and treatments.

Targets pathological angiogenesis in ocular neovascular diseases.

Funding Insights of Vasgen

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Vasgen

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Vasgen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Vasgen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Vasgen

Vasgen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
domain founded_year HQ Location
Small molecule therapeutics for cancer treatment are developed.
domain founded_year HQ Location
MicroRNA-based therapeutics are developed for treating multiple diseases.
domain founded_year HQ Location
Therapeutics for cancer and rare diseases are developed.
domain founded_year HQ Location
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Vasgen

Frequently Asked Questions about Vasgen

When was Vasgen founded?

Vasgen was founded in 2011.

Where is Vasgen located?

Vasgen is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Who is the current CEO of Vasgen?

Salman Rahman is the current CEO of Vasgen. They have also founded this company.

How many employees does Vasgen have?

As of Jul 31, 2021, the latest employee count at Vasgen is 2.

What does Vasgen do?

VASGEN Ltd is a speciality biotech firm based in London, UK, that focuses on innovative therapeutics for ocular and cancer diseases. It utilizes technologies like AbIMP to target metzincin proteases and develop new therapeutic options. The company engages in research, intellectual property management, and partnering with investors for commercial potential, while advancing biomarkers and treatments through clinical arenas.

Who are the top competitors of Vasgen?

Vasgen's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.

What products or services does Vasgen offer?

Vasgen offers AbIMP® Technology, ADAMs Family, and ADAM15.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available